デフォルト表紙
市場調査レポート
商品コード
1212076

多重検出イムノアッセイの世界市場

Multiplex Detection Immunoassays

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.28円
多重検出イムノアッセイの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の多重検出イムノアッセイの市場規模は、2022年に24億米ドルとなり、2022年~2030年の分析期間にかけて3.5%のCAGRで成長し、2030年までに32億米ドルとなると予想されています。

当レポートでは、世界の多重検出イムノアッセイ市場を調査し、市場の概要、市場の促進要因の分析、市場機会、地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋地域
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP13508

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Multiplex Detection Immunoassays Market to Reach $3.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Multiplex Detection Immunoassays estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2022-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Nucleic Acid Based Technique segment is readjusted to a revised 3.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $702.3 Million, While China is Forecast to Grow at 3.4% CAGR

The Multiplex Detection Immunoassays market in the U.S. is estimated at US$702.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$564 Million by the year 2030 trailing a CAGR of 3.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 2.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Select Competitors (Total 14 Featured):

  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Microsynth AG
  • MilliporeSigma
  • Qiagen NV
  • Quansys Biosciences
  • Thermo Fisher Scientific, Inc.
  • Unisensor

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Multiplex Detection Immunoassays - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Food Contamination Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Veterinary Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Multiplex Detection Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Protein-Based Multiplex Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Nucleic Acid Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Biosensor Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • JAPAN
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • CHINA
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • EUROPE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • FRANCE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • GERMANY
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2014, 2023 & 2030

IV. COMPETITION